Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
2.000
-0.030 (-1.48%)
At close: Nov 4, 2024, 4:00 PM
1.970
-0.030 (-1.50%)
Pre-market: Nov 5, 2024, 5:45 AM EST
Esperion Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -98.5 | -209.25 | -233.66 | -269.11 | -143.55 | -97.17 | Upgrade
|
| Depreciation & Amortization | 0.04 | 0.16 | 0.5 | 0.61 | 0.55 | 0.32 | Upgrade
|
| Other Amortization | 1.74 | 1.7 | 1.62 | 1.62 | 1.74 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 12.5 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -0.41 | 0.28 | 0.01 | -0.1 | -0.2 | Upgrade
|
| Stock-Based Compensation | 12.06 | 11.96 | 15.22 | 24.31 | 28.39 | 25.88 | Upgrade
|
| Other Operating Activities | 91.17 | 46.68 | 44.59 | 31.26 | 19.56 | 8.12 | Upgrade
|
| Change in Accounts Receivable | -19.56 | -14.77 | -10.8 | -10.55 | -12.39 | - | Upgrade
|
| Change in Inventory | -38.79 | -30.42 | -0.81 | -18.26 | -16.14 | - | Upgrade
|
| Change in Accounts Payable | 23.06 | 8.68 | 5.6 | -34.1 | 23.11 | -16.06 | Upgrade
|
| Change in Unearned Revenue | 5.04 | 21.9 | -2.81 | 4.66 | -0.49 | 2.15 | Upgrade
|
| Change in Other Net Operating Assets | 13.99 | 28.29 | 5.44 | 5.74 | 1.65 | 6.6 | Upgrade
|
| Operating Cash Flow | -9.76 | -135.49 | -174.83 | -263.81 | -85.18 | -70.34 | Upgrade
|
| Capital Expenditures | -0.15 | - | - | - | -0.87 | -0.95 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | -12.5 | - | Upgrade
|
| Investment in Securities | - | 42.5 | 8.1 | -50.48 | 34.73 | 65.18 | Upgrade
|
| Investing Cash Flow | -0.15 | 42.5 | 8.1 | -50.48 | 21.36 | 64.23 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 280 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -50 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -50 | - | 280 | - | Upgrade
|
| Issuance of Common Stock | 114.56 | 65.97 | 90.85 | 222.45 | 6.63 | 11.77 | Upgrade
|
| Repurchase of Common Stock | -343.75 | - | - | - | -55 | - | Upgrade
|
| Other Financing Activities | 289.93 | -15.51 | -8.24 | 45.77 | -29.91 | 124.42 | Upgrade
|
| Financing Cash Flow | 60.74 | 50.46 | 32.61 | 268.22 | 201.73 | 136.2 | Upgrade
|
| Net Cash Flow | 50.83 | -42.53 | -134.12 | -46.07 | 137.9 | 130.09 | Upgrade
|
| Free Cash Flow | -9.91 | -135.49 | -174.83 | -263.81 | -86.05 | -71.29 | Upgrade
|
| Free Cash Flow Margin | -3.57% | -116.46% | -231.64% | -336.29% | -37.81% | -48.05% | Upgrade
|
| Free Cash Flow Per Share | -0.07 | -1.31 | -2.63 | -9.13 | -3.13 | -2.63 | Upgrade
|
| Cash Interest Paid | 14.72 | 15.51 | 8.02 | - | - | - | Upgrade
|
| Levered Free Cash Flow | 6.91 | -107.14 | -135.56 | -192.19 | -77.82 | -46.28 | Upgrade
|
| Unlevered Free Cash Flow | 41.3 | -71.98 | -101.67 | -164.84 | -65.4 | -41.21 | Upgrade
|
| Change in Net Working Capital | -26.81 | -13.68 | 3.68 | 54.13 | 4.3 | 8.27 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.